Antithrombotische Therapie nach strukturellen kardialen Interventionen: Empfehlung der Arbeitsgruppe Kardiovaskuläre Hämostase und Antithrombotische Therapie (AG19) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK) in Zusammenarbeit mit der Arbeitsgruppe Interventionelle Kardiologie (AG6) – AGIK und der Arbeitsgruppe Klinische Pharmakologie (AG22) der DGK
Research output: Contribution to journal › Research article › Contributed › peer-review
Contributors
Abstract
In recent years, structural cardiac interventions became an important part of cardiovascular medicine. Despite the rapid development and evolution of these interventional techniques, there is a significant lack of evidence regarding the optimal antithrombotic treatment strategy as randomized trials on this issue are missing for most of these interventions. Thus, this manuscript summarizes the current level of evidence. The listed recommendations are based on available data as well as expert opinion and aim to guide physicians in making decisions for the treatment of patients in this setting.
Translated title of the contribution | Antithrombotic therapy after structural cardiac interventions Recommendations of the Working Group on Cardiovascular Hemostasis and Antithrombotic Therapy (AG19) of the German Cardiac Society (DGK) in cooperation with the Working Group on Interventional Cardiology (AG6, AGIK) and the Working Group on Clinical Pharmacology (AG22) of the DGK |
---|
Details
Original language | German |
---|---|
Pages (from-to) | 57-70 |
Number of pages | 14 |
Journal | Der Kardiologe : die Fortbildungszeitschrift der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung |
Volume | 15 |
Issue number | 1 |
Publication status | Published - Feb 2021 |
Peer-reviewed | Yes |
External IDs
ORCID | /0000-0003-2514-9429/work/151437832 |
---|
Keywords
ASJC Scopus subject areas
Keywords
- Dual antiplatelet therapy, MitraClip, Occluder, Oral anticoagulation, TAVI